Polyphenol-rich bergamot extract has been demonstrated to counter oxidative stress and suppress inflammation in endothelial cells, inhibit plaque formation, and improve arterial responsiveness.
BergaMet Polyphenolic Fraction (BPF) is becoming the leading therapy for individuals with metabolic syndrome. In addition to its positive effects on cardiovascular risk factors, this extract also activates AMPK. AMPK is a central regulator of energy and is thus involved in glucose and fatty acid metabolism. “Turning on” AMPK improves insulin sensitivity, promotes glucose uptake in cells, and suppresses the synthesis of glucose in the liver, thus lowering blood sugar. It also stimulates the burning of free fatty acids and facilitates weight control.
BergaMet Polyphenolic Fraction (BPF 47%) has also been found to significantly reduce serum total cholesterol, LDL cholesterol, and triglycerides in human patients with metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). These findings come from a placebo-controlled clinical trial published in 2014, which also found bergamot derivatives may play a preventive role in reducing cardio-metabolic risk by improving NAFLD biomarkers.
Nathealthsolutions is the only nutraceutical company that makes supplements with the most powerful citrus bergamot in the world, from Calabria, Italy, producing a BPF (Bergamot Polyphenolic Fraction) of up to 47%. The bergamot juice that is extracted, concentrated, and standardized in tablet form. Taken twice per day, BergaMet improves your overall lipid profile, improves cardiometabolic health, improves overall arterial function and cardiovascular health.
The only citrus bergamot supplement approved by the prestigious Accademia del Bergamotto is BergaMet.